New all-in-one IVT kit can deliver up to 2X more mRNA and up to 85% lower dsRNA compared to other kits on the market through streamlined mRNA synthesis with efficient capping, increased yield, reduced ...
Quantoom’s customers can now access TriLink’s CleanCap mRNA capping technology; Agreement supports future expansion of essential therapeutics & vaccines in developing countries & regions TriLink’s ...
A research group used a unique 'PureCap' method to produce high purity mRNA vaccines with improved synthesis of proteins that stimulate the immune system and low inflammatory side effects. A research ...
Maximize capping efficiency and minimize double-stranded RNA ("dsRNA") in the manufacturing of self-amplifying mRNA SAN DIEGO, Nov. 10, 2025 /PRNewswire/ -- Primrose Bio, Inc. ("Primrose"), a company ...
SAN DIEGO, May 09, 2023 (GLOBE NEWSWIRE) -- TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has launched its ...
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies and Alphazyme, both part of Maravai LifeSciences, have collaborated to launch CleanScribe™ RNA Polymerase, a novel enzyme that reduces ...
Developers of mRNA therapeutics face an increasingly complex landscape: rising expectations for potency and durability, ...
Join the 13,000+ people who get Times of San Diego in their inbox at 8 a.m. every day – plus breaking news alerts. We’re also adding weekly updates from San Diego neighborhoods soon! Select a location ...
Discoveries that enabled mRNA vaccines against COVID-19 have landed two scientists a Nobel Prize. The Nobel Assembly awarded Katalin Karikó, Ph.D., and Drew Weissman, M.D., Ph.D., the prize for their ...
The donation commemorates the launch of TriLink’s first mRNA synthesis kit featuring CleanCap® capping technology, an all-in-one kit with its innovative products in one box at a competitive price.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback